EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

ENO1–BACE2-mediated LDLR cleavage promotes liver cancer progression by remodelling cholesterol metabolism

Zhikun Li, Kaixiang Fan, Caixia Suo, Xuemei Gu, Chuxu Zhu, Haoran Wei, Liang Chen, Ping Gao, Linchong Sun

Journal of Molecular Cell Biology · 28.06.2025 · 17 (1)

DOI: 10.1093/jmcb/mjaf001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Molecular Cell Biology, online erschienen am 06.02.2025. Verfasst von Zhikun Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, South China University of Technology, Guangzhou 510006, China. Hauptthemen laut MEDLINE: Cholesterol, Liver Neoplasms, Receptors, LDL, Phosphopyruvate Hydratase. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Guangzhou Municipal Science and Technology Bureau, Young Scholars of Southern Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Enolase 1 (ENO1) is a glycolytic enzyme involved in tumour progression that performs a variety of classical and nonclassical functions. However, the mechanism by which it promotes tumour progression is still not fully understood. Here, we found that ENO1 can bind to β-site amyloid precursor protein cleaving enzyme 2 (BACE2), a codependent gene of ENO1, in liver cancer cells. By suppressing lysosomal-dependent degradation, ENO1 stabilizes BACE2 protein level without affecting its messenger RNA level. Further analysis revealed that ENO1 and BACE2 promote low-density lipoprotein receptor (LDLR) cleavage, leading to decreased absorption of exogenous cholesterol. To maintain intracellular cholesterol levels, ENO1 and BACE2 upregulate the expression of genes involved in de novo cholesterol synthesis through a negative feedback mechanism. Both in vitro and in vivo, BACE2 mediates the tumour-promoting effect of ENO1 in liver cancer. Finally, high expression levels of ENO1 and BACE2 and low expression levels of LDLR were detected in clinical hepatocellular carcinoma samples, and abnormal expression of the ENO1–BACE2–LDLR axis was significantly associated with poor prognosis in patients with liver cancer. These data collectively demonstrated that ENO1 functions in protein cleavage by binding to BACE2 and promotes liver cancer progression by reprogramming cholesterol metabolism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholesterolLiver NeoplasmsReceptors, LDLPhosphopyruvate HydrataseTumor Suppressor ProteinsDNA-Binding ProteinsAmyloid Precursor Protein SecretasesCarcinoma, HepatocellularHumansDisease ProgressionAnimalsCell Line, TumorMiceGene Expression Regulation, NeoplasticProteolysisMaleBiomarkers, Tumor

Stichwörter der Autor:innen

BACE2ENO1LDLRcholesterol metabolismliver cancerprotein cleavage

Substanzen

CholesterolReceptors, LDLPhosphopyruvate HydrataseTumor Suppressor ProteinsDNA-Binding ProteinsAmyloid Precursor Protein SecretasesENO1 protein, humanLDLR protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • School of Medicine, South China University of Technology, Guangzhou 510006, China.
  • Medical Research Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou 510080, China.
  • Department of Colorectal Surgery, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou 510180, China.
  • School of Basic Medical Sciences, Division of Life Science and Medicine, University of Science and Technology of China, Hefei 230026, China.

Förderung

  • National Natural Science Foundation of China
  • Guangzhou Municipal Science and Technology Bureau
  • Young Scholars of Southern Medical University

Zitieren

APA

Li, Z., Fan, K., Suo, C., Gu, X., Zhu, C., Wei, H., Chen, L., Gao, P., & Sun, L. (2025). ENO1–BACE2-mediated LDLR cleavage promotes liver cancer progression by remodelling cholesterol metabolism. Journal of Molecular Cell Biology, 17(1). https://doi.org/10.1093/jmcb/mjaf001

Vancouver

Li Z, Fan K, Suo C, Gu X, Zhu C, Wei H, et al. ENO1–BACE2-mediated LDLR cleavage promotes liver cancer progression by remodelling cholesterol metabolism. Journal of Molecular Cell Biology. 2025;17(1). doi:10.1093/jmcb/mjaf001

BibTeX
@article{Li2025,
  author = {Li, Zhikun and Fan, Kaixiang and Suo, Caixia and Gu, Xuemei and Zhu, Chuxu and Wei, Haoran and Chen, Liang and Gao, Ping and Sun, Linchong},
  title = {ENO1–BACE2-mediated LDLR cleavage promotes liver cancer progression by remodelling cholesterol metabolism},
  journal = {Journal of Molecular Cell Biology},
  year = {2025},
  volume = {17},
  number = {1},
  doi = {10.1093/jmcb/mjaf001}
}
Kostenlos starten →